Skip to main navigation
Krystal Biotech, Inc.
  • Contact Us
  • Careers
  • Company
    • Leadership
    • Board of Directors
  • Science
    • Technology
    • Pipeline
    • Manufacturing
    • Therapeutic Areas
    • Medical Professionals
  • Product
    • Vyjuvek
  • Patients
    • Patient Resources
  • Investors
  • Contact Us

Investors

Investor Relations
  • Overview
  • News Releases
  • Events
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Scientific Publications
  • Email Alerts
  • Analyst Coverage
  • Investor FAQs

KB801 First Patient Dosed Update

July 9, 2025 at 8:30 AM EDT

Click here for webcast

Supporting Materials

Click here for presentation 943.8 KB
Krystal Biotech, Inc.
Quick Links
  • Company
  • Science
  • Product
  • Patients
  • Investors
  • Contact Us
  • Careers

Contact Us

Krystal Biotech, Inc.

2100 Wharton St. Suite #701

Pittsburgh, PA 15203

reception is in Suite #310

412-586-5830

inquiries@krystalbio.com
X X

KRYSTAL®, VYJUVEK®, and their associated logos are trademarks owned by Krystal Biotech, Inc. All other trademarks are property of their respective owners.

© Krystal Biotech, Inc. 2023-2026 All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Compliance Program